AI-Driven Patient Ventilation and Aspiration System

A wearable, AI-powered respiratory monitoring device integrated with a tracheostomy or endotracheal connector, predicting and preventing ventilator-associated pneumonia (VAP) through real-time monitoring and adaptive suction control.

The original patent relates to a catheter tube connector for a suction system used with a tracheostomy or endotracheal patient ventilation system. However, the existing system lacks real-time monitoring and adaptive control, leading to a high risk of VAP. The new inventive concept addresses this limitation by incorporating AI-powered respiratory monitoring and adaptive suction control to prevent VAP.

The AI-driven patient ventilation and aspiration system consists of a wearable, AI-powered respiratory monitoring device integrated with a tracheostomy or endotracheal connector. The device predicts and prevents VAP through real-time monitoring of patient data and adaptive suction control. The system includes a neural network trained to detect early signs of VAP and automatically adjusts suction pressure, frequency, and duration to prevent VAP onset. Additionally, the system enables remote monitoring and control of patient ventilation and aspiration through a cloud-based platform, integrating real-time patient data from wearable devices, ventilators, and suction systems.

The new inventive concept introduces the use of AI-powered respiratory monitoring and adaptive suction control to prevent VAP, which is a novel and non-obvious improvement over the original patent. The incorporation of machine learning algorithms, neural networks, and cloud-based remote monitoring and control enables real-time adaptation to patient needs, reducing the risk of VAP and improving patient outcomes.

Alternative embodiments of the inventive concept could include the use of different AI algorithms, sensor types, or communication protocols. Variations could include the integration of additional features, such as real-time patient data analytics or personalized treatment planning.

The AI-driven patient ventilation and aspiration system has significant commercial potential in the healthcare industry, particularly in critical care and respiratory therapy. The system could be marketed as a premium product for hospitals and healthcare facilities, offering improved patient outcomes and reduced healthcare costs.